These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6298148)

  • 1. Comments on the transverse shielding of proton accelerators.
    Tesch K
    Health Phys; 1983 Jan; 44(1):79-82. PubMed ID: 6298148
    [No Abstract]   [Full Text] [Related]  

  • 2. Shielding design for a laser-accelerated proton therapy system.
    Fan J; Luo W; Fourkal E; Lin T; Li J; Veltchev I; Ma CM
    Phys Med Biol; 2007 Jul; 52(13):3913-30. PubMed ID: 17664585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of transverse shielding for proton accelerators using the Moyer model.
    Stevenson GR; Kuei-Lin L; Thomas RH
    Health Phys; 1982 Jul; 43(1):13-29. PubMed ID: 6290422
    [No Abstract]   [Full Text] [Related]  

  • 4. Preliminary shielding assessment for the 100 MeV proton linac (KOMAC).
    Lee YO; Cho YS; Chang J
    Radiat Prot Dosimetry; 2005; 115(1-4):569-72. PubMed ID: 16381787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Energy dependence of the dose equivalent on the primary proton energy--comparison of CASIM and Moyer model calculations.
    Yamaguchi C
    Health Phys; 1986 Dec; 51(6):812-4. PubMed ID: 3023259
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiation protection at low energy proton accelerators.
    Moritz LE
    Radiat Prot Dosimetry; 2001; 96(4):297-309. PubMed ID: 11843080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variance and regression analyses of Moyer model parameter data and their variation with primary proton energy.
    Lieu KL; Stevenson GR; Thomas RH; Thomas SV
    Health Phys; 1984 Mar; 46(3):674-81. PubMed ID: 6321401
    [No Abstract]   [Full Text] [Related]  

  • 8. Proton and heavy ion acceleration facilities for space radiation research.
    Miller J
    Gravit Space Biol Bull; 2003 Jun; 16(2):19-28. PubMed ID: 12959128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation safety design for the J-PARC Project.
    Nakashima H; Nakane Y; Masukawa F; Matsuda N; Oguri T; Nakano H; Sasamoto N; Shibata T; Suzuki T; Miura T; Numajiri M; Nakao N; Hirayama H; Sasaki S
    Radiat Prot Dosimetry; 2005; 115(1-4):564-8. PubMed ID: 16381786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shielding high energy accelerators.
    Stevenson GR
    Radiat Prot Dosimetry; 2001; 96(4):359-71. PubMed ID: 11843085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of radiation shielding for the proton therapy facility at the National Cancer Center in Korea.
    Kim JW; Kwon JW; Lee J
    Radiat Prot Dosimetry; 2005; 115(1-4):271-5. PubMed ID: 16381727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation protection at high energy proton accelerators.
    Silari M; Stevenson GR
    Radiat Prot Dosimetry; 2001; 96(4):311-21. PubMed ID: 11843081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shielding design of an underground experimental area at point 5 of the CERN Super Proton Synchrotron (SPS).
    Mueller MJ; Stevenson GR
    Radiat Prot Dosimetry; 2005; 115(1-4):181-6. PubMed ID: 16381709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shielding for the upgraded Duke Free Electron Laser Laboratory.
    Vylet V
    Radiat Prot Dosimetry; 2005; 115(1-4):207-11. PubMed ID: 16381713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Intensity Proton Accelerator Project in Japan (J-PARC).
    Tanaka S
    Radiat Prot Dosimetry; 2005; 115(1-4):33-43. PubMed ID: 16381679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target station shielding issues at the spallation neutron source.
    Ferguson PD; Gallmeier FX; Iverson EB; Popova II
    Radiat Prot Dosimetry; 2005; 115(1-4):170-5. PubMed ID: 16381707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutron shielding calculations in a proton therapy facility based on Monte Carlo simulations and analytical models: criterion for selecting the method of choice.
    Titt U; Newhauser WD
    Radiat Prot Dosimetry; 2005; 115(1-4):144-8. PubMed ID: 16381702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Spallation Neutron Source (SNS) project: a fertile ground for radiation protection and shielding challenges.
    Gallmeier FX; Ferguson PD; Popova II; Iverson EB
    Radiat Prot Dosimetry; 2005; 115(1-4):23-32. PubMed ID: 16381678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutron radiation area monitoring system for proton therapy facilities.
    Newhauser WD; Ding X; Giragosian D; Nill S; Titt U
    Radiat Prot Dosimetry; 2005; 115(1-4):149-53. PubMed ID: 16381703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose equivalent measurements at a 2.7 GeV proton accelerator and comparison with the Moyer model.
    Bourgois L; Delacroix D; Ferreux L; Masson L
    Health Phys; 1996 Jan; 70(1):36-40. PubMed ID: 7499149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.